OaCP IE LTD
Fast laboratory diagnostics — reducing cancer test time by 97%
- Headquarters
- Cork
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- oacp.it
- Total Funding
- $330K
About
OaCP IE LTD (Oncology and Cytogenetic Products) is an Irish biotech company founded in 2017, headquartered in Cork, Ireland, with roots in research conducted with the University of Bologna. The company develops patented chemical and biotechnological reagents — including its flagship Rapid-ISH and Smart-ISH hybridization buffers — that reduce the time required for genetic cancer diagnostic tests by 97% (from three days to two hours) and cut costs by 50%. OaCP's CE-IVD approved products are used by molecular biology and cytogenetics laboratories worldwide to improve cancer diagnosis, precision medicine, and personal genomics. The company has been backed by SOSV and Bio4Dreams and recognized as a Top 60 startup at the Entrepreneurship World Cup.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account